Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Organellen 100 AB
AB
Dissolved
Org 5593668444
Stockholm
Rental and operating of own or leased real estate · NACE 6820
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 1M
+119% vs 2023
EBITDA margin
865.2%
+3351% vs 2023
Equity ratio
98.5%
Financial strength
Net profit 2024
SEK 8,2M
+164020% vs 2023
EBITDA — year on year
SEK millions
11M
8M
6M
3M
0M
0M
2022
0M
0%
2023
9M
+900%
2024
Key figures
Annual report 2024
Revenue
SEK 1M
+119%
EBITDA
SEK 8,7M
+3351%
Net profit
SEK 8,2M
+164020%
Total assets
SEK 8,4M
+28%
Equity
SEK 8,3M
+7814%
Employees
0
—
Company information
Legal name
Organellen 100 AB
Org number
5593668444
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
22 februari 2022
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget ska äga och förvalta fast och lös egendom, bedriva fastighetsutveckling, samt därmed förenlig verksamhet.
Contact
Address
Stockholm
Email
robin@greengroup.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Rental and operating of own or leased real estate
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
1M
2024
EBITDA
SEK millions
0M
3M
5M
8M
10M
0M
2022
0M
2023
9M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
0
460
1 009
Staff expenses
—
—
—
EBITDA
—
253
8 730
Depreciation & amort.
—
−82
−164
EBIT
0
171
8 566
Net financials
—
−165
−337
Profit before tax
0
6
8 205
Tax
—
−1
1
Net profit
0
5
8 206
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
100
6 610
8 440
Equity
100
105
8 310
Long-term debt
—
5 876
0
Short-term debt
—
630
130
Total debt
—
6 506
130
Financial ratios
5-year trend
EBITDA margin
865.2%
This company
15.8%
Market median
+5376% vs market
2022
2024
Equity ratio
98.5%
This company
38.2%
Market median
+158% vs market
2022
2024
Return on equity
98.7%
This company
18.4%
Market median
+436% vs market
2022
2024
Net profit margin
813.3%
This company
8.1%
Market median
+9941% vs market
2022
2024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
2022
2024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-02-22 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
LJ
Lars Jonny Isaksson
Audit
Audit
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
NB
Niklas Borg
Chairman
2022
RE
Robin Erik Englén
Board of Directors
2022
KG
Karl Gustaf André Grundström
Board of Directors
2022
Former (1)
RB
Rolf Bo Björfors
Board of Directors
2022 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Äppelkusten Holding AB
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Äppelkusten Holding AB
Organellen 100 AB
(this company)
Board network connections
Board members of Organellen 100 AB also hold positions in
0
other companies.
Person
Role here
Other companies
Lars Jonny Isaksson
Audit
0 companies
Niklas Borg
Chairman
0 companies
Robin Erik Englén
Board of Directors
0 companies
Rolf Bo Björfors
Board of Directors
0 companies
Karl Gustaf André Grundström
Board of Directors
0 companies